Navigation Links
Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT)
Date:7/10/2014

t patients or discharge them on outpatient therapy.
  • Preference for oral antibiotics over OPAT: Oral therapies offer the potential to substantially simplify antibiotic treatment compared with therapies that are administered intravenously. Not surprisingly, surveyed ID specialists reported being more likely to prescribe oral formulations of both Cubist's Sivextro (tedizolid) and Tetraphase's emerging drug eravacycline when discharging patients than OPAT with either drug, suggesting oral formulations of these agents will see greater use as discharge therapy.
  • Comments from Decision Resources Group Analyst Hannah E. Cummings, Ph.D.:

    • "Hospitals are actively looking to cut costs and reduce or shorten admissions, and discharging patients on OPAT is an important part of their strategy. OPAT is a particularly attractive treatment modality for patients presenting to the emergency room with an infection requiring IV antibiotic therapy but not necessitating admission. ID specialists and emergency room physicians are frequently involved in identifying and recommending patients for OPAT and will likely be key stakeholders in driving uptake of new OPAT therapies."
    • "Surveyed ID specialists identified a need for new OPAT drugs for infections due to drug-resistant pathogens that are dosed once daily. Although the OPAT market is highly genericized, agents demonstrating benefits in efficacy, dosing-frequency and/or administration, such as Cubist's Cubicin (daptomycin) and Merck's Invanz (ertapenem), have experienced widespread use in the OPAT market. New agents will also have to demonstrate improvements on these key attributes to successfully compete in the OPAT market segment."

    About Decision Resources Group
    Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare indu
    '/>"/>

    SOURCE Decision Resources Group
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention
    2. Beyond the Headlines: What the FDA Decisions on Extended-release and Long-Acting Opioids Mean for People With Pain
    3. WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile
    4. PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
    5. Study Published In Contraception Evaluates Medical Expenditures For Unintended Pregnancies And Potential Cost Impact Of Increased Use Of Long-Acting Reversible Contraception
    6. Purdue Pharma L.P. Comments on FDA Announcement on REMS for Extended-Release and Long-Acting Opioid Analgesics
    7. Applegate CEO Worries FDA Plan To Address Antibiotics In Animal Agriculture Is Too Little, Too Late
    8. AVMA lauds FDA for new regulation of antibiotics in livestock feed
    9. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
    10. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
    11. Antibiotic Resistance 2013: The Antibiotics Development Pipeline and Strategies to Combat Antibiotic Resistance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... CAESAREA, Israel , July 6, 2015 /PRNewswire/ ... enrollment of the first three patients in its ... study is a 184 patient randomized, single blinded ... balloon system to conventional repair or partial repair ... cuff tears.  While InSpace is currently commercially available ...
    (Date:7/6/2015)... , July 6, 2015 Flower Orthopedics, ... concept the FlowerCube™, announced today that it has ... opportunity for significant expansion of the innovative FlowerCube™ ... The approval encompasses Flower Orthopedics, entire product line, ... upper and lower extremities. Consisting of more than ...
    (Date:7/6/2015)... , July 6, 2015 ... initiatives to drive bioinformatics market in Germany ... a recently released TechSci Research report, " Germany Bioinformatics ... Germany is projected to register ... is expected to witness tremendous growth on account of ...
    Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2Flower Orthopedics cleared to enter the European Union 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3
    (Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys in the realm ... the Invokana Ketoacidosis Lawsuit Center . The website provides information on Invokana ... persons wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, heart ...
    (Date:7/7/2015)... ... July 07, 2015 , ... Clarion Safety Systems , ... featured in the latest issue of In Compliance Magazine, a leading source for ... delivers the latest news, standards updates, technical explanations and guidance, as a resource ...
    (Date:7/7/2015)... Washington, DC (PRWEB) , ... July 07, 2015 ... ... Operating Officer and well-known patient advocate, will be recognized by the White House ... , Part of the newly-launched President’s Precision Medicine Initiative, the Champions of Change ...
    (Date:7/7/2015)... ... July 07, 2015 , ... Each year the Holiday Inn ... on a local, national and international level; however, the Holiday Inn now hosts one ... a high impact on the beneficiaries. In September of 2014 they hosted an event ...
    (Date:7/6/2015)... London, UK (PRWEB) , ... July 07, 2015 ... ... segments in the in vitro universe. Increasing incidence of AIDS, advances in the ... the key growth driving forces. Recent advances in detection technologies and genetic engineering ...
    Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 2Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 3Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 4Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 2Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3
    ... to exercise within 6 months , , MONDAY, March 30 ... their own stem cells into the heart muscle appears ... say U.S. researchers. , "The results from this study ... cells could actually be used as a treatment for ...
    ... March 30 TrinityCare Senior Living, Inc. (OTC ... faith-based senior living facilities, today announced that it ... and implement a comprehensive investor relations program for ... investment research and financial communications firm that seeks ...
    ... PharmAthene, Inc. (NYSE Amex: PIP ), ... chemical threats, today reported operational and financial results for ... ended December 31, 2008 and 2007, the Company reported ... Revenues for the full year 2008 consisted primarily of ...
    ... published in the March/April issue of the journal Nursing ... nurses from leaving their jobs and in doing so ... another position or retire early, it dramatically affects a hospital,s ... hospital,s budget may go to paying for nursing turnover costs. ...
    ... CLEVELAND, March 30 Inajo Davis Chappell, Partner ... Resources as the first recipient of the Helen K. Jones ... of understanding the nuances and complexities of the non-profit arena, ... over many years. In addition to a stellar career ...
    ... Bausch & Lomb has announced a partnership in the U.S., ... that helps individuals identify their perfect style type. The firm ... life for women and men through the " See a ... Bausch & Lomb at: http://inr.mediaseed.tv/Bausch_Lomb_36321 ...
    Cached Medicine News:Health News:Stem Cell Injections Seem to Reduce Angina Pain 2Health News:TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel 2Health News:TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel 3Health News:PharmAthene Reports Year End 2008 Financial Results 2Health News:PharmAthene Reports Year End 2008 Financial Results 3Health News:PharmAthene Reports Year End 2008 Financial Results 4Health News:PharmAthene Reports Year End 2008 Financial Results 5Health News:PharmAthene Reports Year End 2008 Financial Results 6Health News:PharmAthene Reports Year End 2008 Financial Results 7Health News:Keeping nurses on the job: Retention is part of the answer to the nursing shortage 2Health News:Recovery Resources to Honor Ulmer & Berne Attorney Inajo Davis Chappell with the Helen K. Jones Woman of Strength Memorial Award 2Health News:VIDEO from Medialink and Bausch & Lomb: Bausch & Lomb Partners With Visual Therapy to Help Women Nationwide 'See a New You' 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: